These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3774116)

  • 1. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW; Shih JC
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes.
    Hamblin MW; Adriaenssens PI; Ariani K; Cawthon RM; Stratford CA; Tan GL; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Mar; 240(3):701-11. PubMed ID: 3559968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artifactual high-affinity and saturable binding of [3H]5-hydroxytryptamine induced by radioligand oxidation.
    Peroutka SJ; Ison PJ; Liu DU; Barrett RW
    J Neurochem; 1986 Jul; 47(1):38-45. PubMed ID: 3711910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of cholesterol on two types of 5-hydroxytryptamine binding sites.
    Shih JC; Ohsawa R
    Neurochem Res; 1983 Jun; 8(6):701-10. PubMed ID: 6621769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
    May PC; Morgan DG; Salo D; Goss JR; Finch CE
    J Neurosci Res; 1988; 20(2):257-62. PubMed ID: 3139891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA; Wolfe BB; Frazer A
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.
    Engel G; Göthert M; Müller-Schweinitzer E; Schlicker E; Sistonen L; Stadler PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):116-24. PubMed ID: 6646239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 May; 50(5):1624-31. PubMed ID: 3361315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
    Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
    Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit.
    Chidlow G; De Santis LM; Sharif NA; Osborne NN
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2238-45. PubMed ID: 7558717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
    Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and localization of 5-HT1P receptors in the guinea pig pancreas.
    Kirchgessner AL; Liu MT; Tamir H; Gershon MD
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G553-66. PubMed ID: 1550243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
    Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
    J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.